Xintela AB
XINT | FN
Overview
Corporate Details
- ISIN(s):
- SE0007756903 (+2 more)
- LEI:
- 549300SMDH1EOLCBQU68
- Country:
- Sweden
- Address:
- MEDICON VILLAGE, 223 81 Lund
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Xintela AB develops regenerative medicine and targeted cancer therapies. Their technology focuses on stem cells and integrin markers.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Sensorion | France | ALSEN | |
|
SenzaGen AB | Sweden | SENZA | |
|
SoftOx Solutions AS | Norway | SOFTX | |
|
Spago Nanomedical AB | Sweden | SPAGO | |
/other/Spermosens_AB_publ-logo.jpg?Expires=1750312611&Signature=VLFeTwzcp3rmL52ztNWVLFJX5iCgAZLyDF6V1mPzDBYXU40vrdMvRb9TFro8qGWOK2rggyj8K7ELrDQFnMHGNfO9n1K69Uy89NJ~iSE-fup9bffdU2sALbJMRvIYTufRbbQdHeAjYFs4ZbCB6sv~LzP~3~PidpxL4hZf7Z7pXmUKLN0NTCWQGb-Wmkb6~ajZotBMgic3J3aPMrnyMDwIZtxwV2kxk0AHBQMhNdu2FKL42UPC073ibDxtuHYECf2KCgQ20EMAE1rFZUuguDmA~5-ieHYshPKBaTeYc~aWN2Ol6eqS5D5qwAzXYVnFx7SUNOusRED0uAkl5i7LnQAZlg__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Spermosens AB (publ) | Sweden | SPERM | |
|
Spexis AG | Switzerland | SPEX | |
|
Sprint Bioscience | Sweden | SPRINT | |
|
Stayble Therapeutics AB | Sweden | STABL | |
|
Stem Cells Spin Spolka Akcyjna | Poland | SCS | |
|
Strategic Partners A/S | Denmark | STRAP |